Skip to main content

Table 6 Sites of initial relapse

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

Site of tumor progression Cohort
  300 mg/m2 400 mg/m2 500 mg/m2
No. of Patients 3 3 23
Locoregional – Infield 2 1 8
Locoregional – Outfield 2 - -
Locoregional – Infield and Distant 1 - 3
Locoregional – Outfield and Distant - - -
Distant only - 1 4
Brain - - 3
Death without Progression - - 1